Loading clinical trials...
Loading clinical trials...
Botulinum Toxin is a Potential Prophylactic Therapy for Minimizing Post-excisional Scarring: A Double Blinded, Randomized Controlled Trial
Conditions
Interventions
Botulinum Toxin
Saline
Locations
1
United States
Icahn School of Medicine at Mount Sinia
New York, New York, United States
Start Date
December 1, 2015
Primary Completion Date
March 1, 2019
Completion Date
March 1, 2019
Last Updated
December 8, 2020
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions